United States Biotechnology & Medical Research

Otonomy Inc (OTIC)

Track

Ticker: OTIC Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 28 Nov 2022
Value US$1,977,460.73 | Price 365.06 | Shares 25,548 (-44.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-29 2022-11-28 S Sale
2.2
CAPPS VICKIE L
Non-Executive Director
25,548 -44.2%
365.06
US$1,977,461 		25,548 -44.2% 365.06 US$1,977,461
2022-03-29 2022-03-28 S Sale
Foster Alan Charles

Chief Scientific Officer

Officer
67,110 +19.5%
284.28
US$1,529,154 		67,110 +19.5% 284.28 US$1,529,154
2022-03-29 2022-03-28 S Sale
Cayer Paul E

Ch. Financial & Business Offcr

Officer
51,193 -39.1%
267.89
US$3,696,211 		51,193 -39.1% 267.89 US$3,696,211
2022-03-29 2022-03-28 S Sale
Savel Robert Michael II

Chief Technical Officer

Officer
3,325 -2.2%
2.41
US$8,023 		3,325 -2.2% 2.41 US$8,023
2022-03-29 2022-03-28 S Sale
Weber David Allen

President & CEO

Executive Director
11,243 -2.9%
2.41
US$27,129 		11,243 -2.9% 2.41 US$27,129
2022-03-29 2022-03-25 S Sale
Foster Alan Charles

Chief Scientific Officer

Officer
1,827 -1.0%
2.39
US$4,363 		1,827 -1.0% 2.39 US$4,363
2022-03-29 2022-03-25 S Sale
Cayer Paul E

Ch. Financial & Business Offcr

Officer
4,015 -1.7%
2.39
US$9,588 		4,015 -1.7% 2.39 US$9,588
2022-03-29 2022-03-25 S Sale
Savel Robert Michael II

Chief Technical Officer

Officer
2,374 -1.6%
2.39
US$5,669 		2,374 -1.6% 2.39 US$5,669
2022-03-29 2022-03-25 S Sale
Weber David Allen

President & CEO

Executive Director
8,026 -2.0%
2.39
US$19,166 		8,026 -2.0% 2.39 US$19,166
2021-03-03 2021-03-03 S Sale
4.0
Lichter Jay
Non-Executive Director
113,935 -100.0%
2.70
US$307,397 		113,935 -100.0% 2.70 US$307,397
2021-03-03 2021-03-03 S Sale
4.0
Lichter Jay
Non-Executive Director
207,245 -100.0%
2.70
US$559,147 		207,245 -100.0% 2.70 US$559,147
2021-03-02 2021-03-02 S Sale
4.0
Lichter Jay
Non-Executive Director
138,199 -54.8%
2.90
US$400,639 		138,199 -54.8% 2.90 US$400,639
2021-03-02 2021-03-02 S Sale
4.0
Lichter Jay
Non-Executive Director
251,375 -54.8%
2.90
US$728,736 		251,375 -54.8% 2.90 US$728,736
2021-03-02 2021-03-01 S Sale
4.0
Lichter Jay
Non-Executive Director
61,619 -19.6%
2.86
US$175,984 		61,619 -19.6% 2.86 US$175,984
2021-03-02 2021-03-01 S Sale
4.0
Lichter Jay
Non-Executive Director
112,081 -19.6%
2.86
US$320,103 		112,081 -19.6% 2.86 US$320,103
2021-03-02 2021-02-26 S Sale
4.0
Lichter Jay
Non-Executive Director
117,262 -27.2%
2.83
US$331,851 		117,262 -27.2% 2.83 US$331,851
2021-03-02 2021-02-26 S Sale
4.0
Lichter Jay
Non-Executive Director
213,292 -27.2%
2.83
US$603,616 		213,292 -27.2% 2.83 US$603,616
2021-02-25 2021-02-25 S Sale
4.0
Lichter Jay
Non-Executive Director
110,361 -20.4%
2.95
US$326,006 		110,361 -20.4% 2.95 US$326,006
2021-02-25 2021-02-25 S Sale
4.0
Lichter Jay
Non-Executive Director
200,739 -20.4%
2.95
US$592,983 		200,739 -20.4% 2.95 US$592,983
2021-02-25 2021-02-24 S Sale
4.0
Lichter Jay
Non-Executive Director
178,484 -24.8%
2.98
US$532,239 		178,484 -24.8% 2.98 US$532,239
2021-02-25 2021-02-24 S Sale
4.0
Lichter Jay
Non-Executive Director
324,651 -24.8%
2.98
US$968,109 		324,651 -24.8% 2.98 US$968,109
2021-02-25 2021-02-23 S Sale
4.0
Lichter Jay
Non-Executive Director
95,113 -11.7%
2.89
US$274,686 		95,113 -11.7% 2.89 US$274,686
2021-02-25 2021-02-23 S Sale
4.0
Lichter Jay
Non-Executive Director
173,005 -11.7%
2.89
US$499,638 		173,005 -11.7% 2.89 US$499,638
2017-06-27 2017-06-26 PlS Planned sale LOUMEAU ERIC J

GC & Chief Compliance Officer
1,206 -100.0%
18.75
US$22,612 		1,206 -100.0% 18.75 US$22,612
2017-06-27 2017-06-23 PlS Planned sale LOUMEAU ERIC J

GC & Chief Compliance Officer
2,316 -65.8%
18.50
US$42,846 		2,316 -65.8% 18.50 US$42,846
2016-11-22 2016-11-21 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
1,456 -13.3%
18.07
US$26,303 		1,456 -13.3% 18.07 US$26,303
2016-11-22 2016-11-18 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
9,169 -49.2%
18.07
US$165,703 		9,169 -49.2% 18.07 US$165,703
2016-09-08 2016-09-06 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
5,304 -35.9%
17.95
US$95,207 		5,304 -35.9% 17.95 US$95,207
2016-09-08 2016-09-06 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
3,813 -20.5%
17.95
US$68,443 		3,813 -20.5% 17.95 US$68,443
2016-09-08 2016-09-06 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
12,133 -39.5%
17.95
US$217,787 		12,133 -39.5% 17.95 US$217,787
2015-12-22 2015-12-21 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
8,061 -47.5%
28.38
US$228,753 		8,061 -47.5% 28.38 US$228,753
2015-12-22 2015-12-21 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
13,189 -43.7%
27.83
US$367,074 		13,189 -43.7% 27.83 US$367,074
2015-12-18 2015-12-17 PlS Planned sale Cayer Paul E

Ch. Financial & Business Offcr

Officer
300 -3.0%
30.19
US$9,056 		300 -3.0% 30.19 US$9,056
2015-12-18 2015-12-17 PlS Planned sale Cayer Paul E

Ch. Financial & Business Offcr

Officer
2,700 -21.4%
29.65
US$80,045 		2,700 -21.4% 29.65 US$80,045
2015-12-16 2015-12-15 PlS Planned sale Weber David Allen

President & CEO

Executive Director
5,208 -22.8%
27.25
US$141,917 		5,208 -22.8% 27.25 US$141,917
2015-12-16 2015-12-14 S Sale Savel Robert Michael II

Chief Technical Officer

Officer
100 -7.4%
27.70
US$2,770 		100 -7.4% 27.70 US$2,770
2015-12-16 2015-12-14 S Sale Savel Robert Michael II

Chief Technical Officer

Officer
1,289 -48.7%
27.26
US$35,136 		1,289 -48.7% 27.26 US$35,136
2015-12-16 2015-12-14 S Sale Savel Robert Michael II

Chief Technical Officer

Officer
1,289 -32.8%
26.15
US$33,706 		1,289 -32.8% 26.15 US$33,706
2015-12-16 2015-12-14 PlS Planned sale Savel Robert Michael II

Chief Technical Officer

Officer
2,322 -37.1%
25.14
US$58,363 		2,322 -37.1% 25.14 US$58,363
2015-11-30 2015-11-30 S Sale ORBIMED ADVISORS LLC Non-Executive Director
590 -0.0%
29.22
US$17,240 		590 -0.0% 29.22 US$17,240
2015-11-30 2015-11-30 S Sale ORBIMED ADVISORS LLC Non-Executive Director
2,716 -0.1%
28.64
US$77,786 		2,716 -0.1% 28.64 US$77,786
2015-11-30 2015-11-30 S Sale Khuong Chau Quang Non-Executive Director
590 -0.0%
29.22
US$17,240 		590 -0.0% 29.22 US$17,240
2015-11-30 2015-11-30 S Sale Khuong Chau Quang Non-Executive Director
2,716 -0.1%
28.64
US$77,786 		2,716 -0.1% 28.64 US$77,786
2015-11-30 2015-11-27 S Sale ORBIMED ADVISORS LLC Non-Executive Director
29,000 -1.5%
28.97
US$840,130 		29,000 -1.5% 28.97 US$840,130
2015-11-30 2015-11-27 S Sale Khuong Chau Quang Non-Executive Director
29,000 -1.5%
28.97
US$840,130 		29,000 -1.5% 28.97 US$840,130
2015-11-30 2015-11-25 S Sale ORBIMED ADVISORS LLC Non-Executive Director
34,800 -1.8%
28.91
US$1,006,068 		34,800 -1.8% 28.91 US$1,006,068
2015-11-30 2015-11-25 S Sale Khuong Chau Quang Non-Executive Director
34,800 -1.8%
28.91
US$1,006,068 		34,800 -1.8% 28.91 US$1,006,068
2015-11-24 2015-11-24 S Sale Khuong Chau Quang Non-Executive Director
36,100 -1.8%
28.75
US$1,037,875 		36,100 -1.8% 28.75 US$1,037,875
2015-11-24 2015-11-24 S Sale ORBIMED ADVISORS LLC Non-Executive Director
36,100 -1.8%
28.75
US$1,037,875 		36,100 -1.8% 28.75 US$1,037,875
2015-11-24 2015-11-23 S Sale Khuong Chau Quang Non-Executive Director
80,800 -4.0%
28.45
US$2,298,760 		80,800 -4.0% 28.45 US$2,298,760
2015-11-24 2015-11-23 S Sale ORBIMED ADVISORS LLC Non-Executive Director
80,800 -4.0%
28.45
US$2,298,760 		80,800 -4.0% 28.45 US$2,298,760
2015-11-24 2015-11-20 S Sale Khuong Chau Quang Non-Executive Director
83,900 -4.0%
28.59
US$2,398,701 		83,900 -4.0% 28.59 US$2,398,701
2015-11-24 2015-11-20 S Sale ORBIMED ADVISORS LLC Non-Executive Director
83,900 -4.0%
28.59
US$2,398,701 		83,900 -4.0% 28.59 US$2,398,701
2015-11-19 2015-11-19 S Sale ORBIMED ADVISORS LLC Non-Executive Director
127,300 -5.7%
28.60
US$3,640,780 		127,300 -5.7% 28.60 US$3,640,780
2015-11-19 2015-11-19 S Sale Khuong Chau Quang Non-Executive Director
127,300 -5.7%
28.60
US$3,640,780 		127,300 -5.7% 28.60 US$3,640,780
2015-11-19 2015-11-17 S Sale ORBIMED ADVISORS LLC Non-Executive Director
200 -0.0%
29.09
US$5,818 		200 -0.0% 29.09 US$5,818
2015-11-19 2015-11-17 S Sale Khuong Chau Quang Non-Executive Director
200 -0.0%
29.09
US$5,818 		200 -0.0% 29.09 US$5,818
2015-11-19 2015-11-17 S Sale ORBIMED ADVISORS LLC Non-Executive Director
10,898 -0.5%
28.80
US$313,862 		10,898 -0.5% 28.80 US$313,862
2015-11-19 2015-11-17 S Sale Khuong Chau Quang Non-Executive Director
10,898 -0.5%
28.80
US$313,862 		10,898 -0.5% 28.80 US$313,862
2015-11-17 2015-11-17 PlS Planned sale Cayer Paul E

Ch. Financial & Business Offcr

Officer
3,000 -23.8%
28.69
US$86,057 		3,000 -23.8% 28.69 US$86,057
2015-11-17 2015-11-16 S Sale Weber David Allen

President & CEO

Executive Director
100 -0.6%
29.25
US$2,925 		100 -0.6% 29.25 US$2,925
2015-11-17 2015-11-16 PlS Planned sale Weber David Allen

President & CEO

Executive Director
5,108 -22.4%
28.56
US$145,887 		5,108 -22.4% 28.56 US$145,887
2015-11-13 2015-11-13 PlS Planned sale Weber David Allen

President & CEO

Executive Director
10,416 -95.1%
30.95
US$322,375 		10,416 -95.1% 30.95 US$322,375
2015-11-12 2015-11-11 PlS Planned sale Cayer Paul E

CFO/Ch. Business Offcr & Sec.

Officer
3,000 -23.8%
24.95
US$74,850 		3,000 -23.8% 24.95 US$74,850
2015-11-12 2015-11-11 PlS Planned sale Weber David Allen

President & CEO

Executive Director
5,208 -90.6%
24.95
US$129,940 		5,208 -90.6% 24.95 US$129,940
2015-09-22 2015-09-21 PlS Planned sale LeBel Carl

Chief Scientific Officer

Officer
21,250 -70.4%
24.36
US$517,576 		21,250 -70.4% 24.36 US$517,576
2015-09-18 2015-09-17 PlS Planned sale Cayer Paul E

CFO/Ch. Business Offcr & Sec.

Officer
3,000 -23.8%
24.95
US$74,850 		3,000 -23.8% 24.95 US$74,850
2015-09-16 2015-09-15 PlS Planned sale Weber David Allen

President & CEO

Executive Director
5,216 -90.6%
24.95
US$130,139 		5,216 -90.6% 24.95 US$130,139
2015-09-15 2015-09-14 PlS Planned sale Savel Robert Michael II

Chief Technical Officer

Officer
5,000 -79.9%
23.98
US$119,896 		5,000 -79.9% 23.98 US$119,896
2015-06-17 2015-06-15 PlS Planned sale Savel Robert Michael II

Chief Technical Officer

Officer
25,000 -95.2%
23.73
US$593,285 		25,000 -95.2% 23.73 US$593,285
2015-05-27 2015-05-22 B Purchase CAPPS VICKIE L Non-Executive Director
1,600 +inf%
24.35
US$38,960 		1,600 +inf% 24.35 US$38,960
2015-05-27 2015-05-22 B Purchase CAPPS VICKIE L Non-Executive Director
3,400 +inf%
24.36
US$82,808 		3,400 +inf% 24.36 US$82,808
2014-08-21 2014-08-19 B Purchase Novo A/S

SEE REMARKS

Large shareholder
15,690 +0.7%
15.50
US$243,135 		15,690 +0.7% 15.50 US$243,135
2014-08-19 2014-08-18 B Purchase Novo A/S

SEE REMARKS

Large shareholder
171,875 +8.6%
16.00
US$2,750,000 		171,875 +8.6% 16.00 US$2,750,000
2014-08-19 2014-08-18 B Purchase Avalon Ventures VIII LP Large shareholder
109,375 +15.5%
16.00
US$1,750,000 		109,375 +15.5% 16.00 US$1,750,000
Explore more

More insider trading research around Otonomy Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America